Your browser doesn't support javascript.
loading
Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation
Daniel Wrapp; Nianshuang Wang; Kizzmekia S Corbett; Jory A Goldsmith; Ching-Lin Hsieh; Olubukola Abiona; Barney S Graham; Jason S McLellan.
Afiliação
  • Daniel Wrapp; University of Texas at Austin
  • Nianshuang Wang; The University of Texas at Austin
  • Kizzmekia S Corbett; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Jory A Goldsmith; The University of Texas at Austin
  • Ching-Lin Hsieh; The University of Texas at Austin
  • Olubukola Abiona; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Barney S Graham; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • Jason S McLellan; The University of Texas at Austin
Preprint em Inglês | bioRxiv | ID: ppbiorxiv-944462
Artigo de periódico
Um artigo publicado em periódico científico está disponível e provavelmente é baseado neste preprint, por meio do reconhecimento de similaridade realizado por uma máquina. A confirmação humana ainda está pendente.
Ver artigo de periódico
ABSTRACT
The outbreak of a novel betacoronavirus (2019-nCov) represents a pandemic threat that has been declared a public health emergency of international concern. The CoV spike (S) glycoprotein is a key target for urgently needed vaccines, therapeutic antibodies, and diagnostics. To facilitate medical countermeasure (MCM) development we determined a 3.5 [A]-resolution cryo-EM structure of the 2019-nCoV S trimer in the prefusion conformation. The predominant state of the trimer has one of the three receptor-binding domains (RBDs) rotated up in a receptor-accessible conformation. We also show biophysical and structural evidence that the 2019-nCoV S binds ACE2 with higher affinity than SARS-CoV S. Additionally we tested several published SARS-CoV RBD-specific monoclonal antibodies and found that they do not have appreciable binding to nCoV-2019 S, suggesting antibody cross-reactivity may be limited between the two virus RBDs. The atomic-resolution structure of 2019-nCoV S should enable rapid development and evaluation of MCMs to address the ongoing public health crisis.
Licença
cc_by
Texto completo: Disponível Coleções: Preprints Base de dados: bioRxiv Tipo de estudo: Experimental_studies / Rct Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: bioRxiv Tipo de estudo: Experimental_studies / Rct Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
...